Radiotherapy Response in Microsatellite Instability Related Rectal Cancer

참고문헌 (73)

1. Autralian Institute of Health and Welfare (AIHW), "Australian cancer incidence and mortality books" (2010), AIHW
2. Wolpin BM, "Adjuvant treatment of colorectal cancer", CA Cancer J Clin, 57, pp.168~185 (2007)
3. Dorudi S, "Surgery for colorectal cancer", Br Med Bull, 64, pp.101~118 (2002)
4. Law WL, "Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients", Ann Surg, 240, pp.260~268 (2004)
5. Colorectal Cancer Collaborative Group, "Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials", Lancet, 358, pp.1291~1304 (2001)
6. Glimelius B, "A systematic overview of radiation therapy effects in rectal cancer", Acta Oncol, 42, pp.476~492 (2003)
7. Ortholan C, "Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials", Dis Colon Rectum, 49, pp.302~310 (2006)
8. Folkesson J, "Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate", J Clin Oncol, 23, pp.5644~5650 (2005)
9. Peeters KC, "The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma", Ann Surg, 246, pp.693~701 (2007)
10. Berger C, "Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications", Int J Radiat Oncol Biol Phys, 37, pp.619~627 (1997)
11. Wheeler JM, "Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system", Dis Colon Rectum, 45, pp.1051~1056 (2002)
12. Ryan R, "Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer", Histopathology, 47, pp.141~146 (2005)
13. Spitz FR, "p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer", Clin Cancer Res, 3, pp.1685~1690 (1997)
14. Dworak O, "Pathological features of rectal cancer after preoperative radiochemotherapy", Int J Colorectal Dis, 12, pp.19~23 (1997)
15. Mandard AM, "Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations", Cancer, 73, pp.2680~2686 (1994)
16. Morgan MJ, "Histological tumour response to pre-operative combined modality therapy in locally advanced rectal cancer", Colorectal Dis, 4, pp.177~183 (2002)
17. Losi L, "Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy", Int J Colorectal Dis, 21, pp.645~651 (2006)
18. Rodel C, "Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer", J Clin Oncol, 23, pp.8688~8696 (2005)
19. Vecchio FM, "The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer", Int J Radiat Oncol Biol Phys, 62, pp.752~760 (2005)
20. Rosenberg R, "Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival", J Surg Oncol, 97, pp.8~13 (2008)
21. Edge SB, "AJCC cancer staging manual" (2010), Springer
22. Marijnen CA, "Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial", J Clin Oncol, 20, pp.817~825 (2002)
23. Peeters KC, "Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients. A Dutch colorectal cancer group study", J Clin Oncol, 23, pp.6199~6206 (2005)
24. Marijnen CA, "Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial", J Clin Oncol, 23, pp.1847~1858 (2005)
25. Zlobec I, "A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods", Clin Cancer Res, 11, pp.5440~5443 (2005)
26. Rödel F, "Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models", Int J Radiat Oncol Biol Phys, 71, pp.247~255 (2008)
27. Negroni A, "Radioresistance in a tumour cell line correlates with radiation inducible Ku 70", 80 end-binding activity, 2008, pp.84, 265~276
28. Bengala C, "Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer", Ann Oncol, 20, pp.469~474 (2009)
29. Ghadimi BM, "Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy", J Clin Oncol, 23, pp.1826~1838 (2005)
30. Watanabe T, "Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles", Cancer Res, 66, pp.3370~3374 (2006)
31. Kim IJ, "Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer", Dis Colon Rectum, 50, pp.1342~1353 (2007)
32. Kuremsky JG, "Biomarkers for response to neoadjuvant chemoradiation for rectal cancer", Int J Radiat Oncol Biol Phys, 74, pp.673~688 (2009)
33. Smith FM, "Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy", Eur J Surg Oncol, 32, pp.55~64 (2006)
34. Zhou BB, "The DNA damage response: putting checkpoints in perspective", Nature, 408, pp.433~439 (2000)
35. Shiloh Y, "The ATM-mediated DNA-damage response: taking shape", Trends Biochem Sci, 31, pp.402~410 (2006)
36. D’Amours D, "The Mre11 complex: at the crossroads of dna repair and checkpoint signalling", Nat Rev Mol Cell Biol, 3, pp.317~327 (2002)
37. Durocher D, "DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?", Curr Opin Cell Biol, 13, pp.225~231 (2001)
38. Löbrich M, "The impact of a negligent G2", M checkpoint on genomic instability and cancer induction, 2007, pp.7, 861~869
39. van Gent DC, "Non-homologous end-joining, a sticky affair", Oncogene, 26, pp.7731~7740 (2007)
40. Zha S, "Mre11: roles in DNA repair beyond homologous recombination", Nat Struct Mol Biol, 16, pp.798~800 (2009)
41. Kunkel TA, "DNA mismatch repair", Annu Rev Biochem, 74, pp.681~710 (2005)
42. de la Chapelle A, "Microsatellite instability", N Engl J Med, 349, pp.209~210 (2003)
43. Vogelstein B, "Genetic alterations during colorectal-tumor development", N Engl J Med, 319, pp.525~532 (1988)
44. Walther A, "Genetic prognostic and predictive markers in colorectal cancer", Nat Rev Cancer, 9, pp.489~499 (2009)
45. Umar A, "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability", J Natl Cancer Inst, 96, pp.261~268 (2004)
46. Haydon AM, "Emerging pathways in colorectal-cancer development", Lancet Oncol, 3, pp.83~88 (2002)
47. Popat S, "Systematic review of microsatellite instability and colorectal cancer prognosis", J Clin Oncol, 23, pp.609~618 (2005)
48. Longley DB, "5-fluorouracil: mechanisms of action and clinical strategies", Nat Rev Cancer, 3, pp.330~338 (2003)
49. Meyers M, "DNA mismatch repair-dependent response to fluoropyrimidine-generated damage", J Biol Chem, 280, pp.5516~5526 (2005)
50. Sargent DJ, "Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer", J Clin Oncol, 28, pp.3219~3226 (2010)
51. Kerr DJ, "Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?", J Clin Oncol, 28, pp.3210~3212 (2010)
52. Umar A, "Testing guidelines for hereditary non-polyposis colorectal cancer", Nat Rev Cancer, 4, pp.153~158 (2004)
53. Vasen HF, "Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)", J Med Genet, 44, pp.353~362 (2007)
54. Lindor NM, "Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors", J Clin Oncol, 20, pp.1043~1048 (2002)
55. Thibodeau SN, "Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1", Cancer Res, 58, pp.1713~1718 (1998)
56. Niessen RC, "Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer", Gut, 55, pp.1781~1788 (2006)
57. de Jong AE, "Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer", Clin Cancer Res, 10, pp.972~980 (2004)
58. Hendriks YM, "Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome)", Gastroenterology, 130, pp.312~322 (2006)
59. Ward RL, "Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified", J Pathol, 207, pp.377~384 (2005)
60. Ham MF, "Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability", Cancer Sci, 97, pp.226~234 (2006)
61. Giannini G, "Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability", Oncogene, 23, pp.2640~2647 (2004)
62. Miquel C, "Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability", Oncogene, 26, pp.5919~5926 (2007)
63. Zhang Y, "Suppressed expression of non-DSB repair genes inhibits gamma-radiation-induced cytogenetic repair and cell cycle arrest", DNA Repair (Amst), 7, pp.1835~1845 (2008)
64. Zhang Y, "Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair", Curr Genomics, 10, pp.250~258 (2009)
65. Chen J, "Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements", Proc Natl Acad Sci U S A, 102, pp.4813~4818 (2005)
66. Franchitto A, "The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase", Oncogene, 22, pp.2110~2120 (2003)
67. Habraken Y, "Differential involvement of the hMRE11", hRAD50, Oncogene, pp.2003, 22[DOI]
68. Janssens S, "Signals from within: the DNA-damage-induced NF-kappaB response", Cell Death Differ, 13, pp.773~784 (2006)
69. Zhang Y, "Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair", Curr Genomics, 10, pp.250~258 (2009)
70. International Human Genome Sequencing Consortium, "Finishing the euchromatic sequence of the human genome", Nature, 431, pp.931~945 (2004)
71. Venter JC, "The sequence of the human genome", Science, 291, pp.1304~1351 (2001)
72. Sherlock G, "Of fish and chips", Nat Methods, 2, pp.329~330 (2005)
73. Kell DB, "Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era", Bioessays, 26, pp.99~105 (2004)

관련 논문AI추천